[¹⁸F]fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) with dual-time-point imaging was accurate in diagnosing  breast cancer recurrence with only a small number of false-positive cases, a study published in the Journal of Clinical Oncology has shown. {read more here}